9th Annual Biomarkers Congress
WIN Symposium in personalized cancer medicine
Palais des Congres

Paris, France
mm
   Deadlines
   ---------

     *  Abstract Deadline:
       15th May 2010

     *  Registration Deadline:
       4th July 2010


   Speakers
   --------

   Jose Baselga, Julio Celis, Soo Khee Chee, Stephen Friend, Richard
   Goldberg, Giuseppe Giaconne, Samir Hanash, Leroy Hood, Waun Ki Hong,
   Olli Kallioniemi, Guido Kroemer, Edison Liu, Lisa McShane, John
   Mendelsohn, Anil Potti, Lajos Pusztai, Richard Schilsky, George Simon,
   Jean-Charles Soria

   The WIN Symposium is supported by its media partner the Nature
   Publishing Group, the event will present breakthrough scientific
   technologies and achievements in personalized cancer medicine, with a
   special focus on individualized treatment and early diagnosis of
   cancer.

   This unique event brings together a broad international audience
   including experts in oncology such as physicians, scientists, cancer
   researchers, pharmaceutical and biotechnology companies, healthcare
   organizations and patient advocates from around the World to offer a
   strategic alliance and vision on personalized medicine in cancer.

   Organizers
   www.kdm-communications.com
   www.winconsortium.org

Schedule of Presentations:

Wednesday, July 7, 2010
07:30:00 REGISTRATION, COFFEE
08:30:00 Welcome address JOHN MENDELSOHN
08:45:00 Integrated medicine and scientific concepts to shift to future modern oncology Guo-Liang Jiang, Alexander Eggermont
09:00:00 Keynote Lecture | The shift from the past to the future modern oncology. The P4 Integrative Medicine. Leroy E Hood
09:25:00 Individualized prevention, early detection and treatment as ways to decrease cancer mortality and improve patient outcomes. JOHN MENDELSOHN
09:50:00 The continuum from basic and translational research to clinical application: challenges and societal needs. The model of comprehensive cancer and international alliances. THOMAS TURSZ
10:15:00 Same challenges, different population and solutions: where do we stand in early diagnosis and personalized medicine across the continents? SOO KHEE CHEE
10:40:00 COFFEE BREAK AND NETWORK DISCUSSIONS
11:00:00 Advanced Scientific Concepts on Personalized Medicine MANFRED SCHMITT
11:10:00 Keynote Lecture | First understand then cure: the human genome to render the clues for the next generation of treatments. Edison T Liu
11:40:00 Use of bionetworks to understand cancer causality: revisiting approved drugs. Stephen Friend
12:10:00 Personalized targeted therapy in lung cancer: winning the battle and paradigm shift. Waun Ki Hong
12:35:00 Optimal ways to integrate chemotherapy and targeted therapies in colorectal cancer. Richard M Goldberg
12:50:00 LUNCH AND NETWORK DISCUSSIONS
13:55:00 Breakthrough in early diagnosis of cancer: scientific and technological achievements (1) JOHNATHAN KNOWLES
14:00:00 Keynote Lecture | Combining multiple high-throughput technologies in cancer diagnostics and therapy selection. Olli Kallioniemi
14:25:00 Development of CastPCR-based universal serum biomarker set for cancer diagnosis and follow-up. CAIFU CHEN
14:50:00 Advanced imaging for early diagnosis and early assessment of response. ROBERT DANN
15:15:00 Bioreactomics concept for serum diagnosis of cancerous state. ANGEL PORGADOR
15:40:00 COFFEE BREAK, POSTER SESSION 1 AND NETWORK DISCUSSIONS
16:25:00 Breakthrough in early diagnosis of cancer: scientific and technological achievements (2) Olli Kallioniemi
16:30:00 Keynote Lecture | The Early Detection Initiative at the Fred Hutchinson Cancer Research Center: a combinatorial technological approach to develop blood tests for early cancer detection. Samir Hanash
16:55:00 The concept of One day Diagnosis Unit for Breast Cancer to improve healthcare: 5-year clinical and research results. Suzette Delaloge
17:20:00 Next generation of biomarkers and tracers for increased diagnostic sensitivity of lung cancer. JURI GELOVANI
17:45:00 Early diagnosis, the cornerstone of the Shanghai Centre Strategy: application to solid malignant tumors. DINGWEY YE
18:15:00 Where do we stand in today’s worldwide screening and early diagnosis? Paradigm of oral and cervical cancer. RITA MULHERKAR
18:45:00 WELCOME RECEPTION PALAIS DE CONGRÈS
Thursday, July 8, 2010
08:20:00 Breakthrough in individualized cancer treatment: new scientific concepts and technological achievements (1) Ignacio I. Wistuba
08:30:00 Keynote Lecture | The right drug for the right patient at the right time: what remains to be done? WIN Consortium goals. RICHARD SCHILSKY
09:00:00 To die or not to die through apoptosis: revisiting the concept of drug response and predicting the efficacy for individualized treatment. G. Kroemer
09:25:00 From MADe IT to iMAP: challenges of personalizing therapy in a constantly changing clinical environment. GEORGE SIMON
09:50:00 Phase II and III clinical trial design and endpoints in targeted therapy era-future goals and challenges. Giuseppe Giaccone
10:15:00 Approaches to individualized treatment in pancreatic cancer: from research to clinical application. MANUEL HIDALGO
10:40:00 COFFEE BREAK AND NETWORK DISCUSSIONS
11:00:00 Breakthrough in individualized cancer treatment: innovative therapeutic developments (2) JOHN MENDELSOHN
11:10:00 Keynote Lecture | The concept of selection of individualized treatments based on molecular portraits of tumors. JEAN CHARLES SORIA
11:35:00 Rationale genomic approaches to dissect lung cancer biology: a clue for clinical application. ANIL POTTI
12:00:00 Strategies for rational radiotherapy regimens and prediction of efficacy. ZHANG ZI
12:25:00 Innovative targeted agents and their optimal development. JOSÉ BASELGA
12:50:00 The dark side of targeted therapies: in silico modelling for prediction of secondary mutations. MARCO PIEROTTI
13:10:00 LUNCH AND NETWORK DISCUSSIONS
14:25:00 Innovative Biomarker developments and strategies in personalized cancer treatments Edison T Liu
14:30:00 Keynote Lecture | Challenges in the development and validation of biomarker signatures for personalized medicine: Lisa M McShane
15:00:00 Integration of systems biology concepts into clinical trials. Lajos Pusztai
15:25:00 Cancer biomarkers uPA and PAI-1 to tailor adjuvant systemic treatment in breast cancer: the NNBC-3 trial. CHRISTOPH THOMSSEN, MANFRED SCHMITT
15:50:00 New biomarker strategies for prediction of drug response in lung cancer treatment: virtual biopsies and circulating biomarkers. FIONA BLACKHALL
16:15:00 Negative biomarker studies: where are they? A proposal for a biomarker studies comprehensive database inside WIN Consortium. FABRICE ANDRE
16:40:00 COFFEE BREAK, POSTER SESSION 2 AND NETWORK DISCUSSIONS
17:20:00 New standards in biorepositories and biospecimen research: a cornerstone for personalized cancer care THOMAS TURSZ
17:25:00 Keynote Lecture | Standardization of biospecimen repositories, a prerequisite for worldwide conducted investigations. CAROLYN COMPTON
17:50:00 Next sequencing generation: characterisation of small cell lung cancer genome using paired end sequencing. PHIL STEPHENS
17:55:00 Advanced bioanalytical measurement technologies for personalized cancer medicine. NEIL COOK
18:15:00 A technological shift to address a paradox: VLADIMIR LAZAR, ZSOFIA BALOGH
18:40:00 Technological shifts enabling predicting survival in interferon-treated patients. Alexander Eggermont
20:30:00 GALA DINNER
Friday, July 9, 2010
08:25:00 Regulatory, financial and societal challenges of new technologies and methods Ignacio I. Wistuba
08:30:00 Keynote Lecture | Societal challenges of personalized medicine: STANLEY HAMILTON, JU CE
09:00:00 Molecular approaches towards functional diagnosis of genetic predisposition to cancer. ASHER SALMON
09:25:00 Personalized medicine in cancer: where research meets clinical care. The Canadian Perspective. Gerald Batist
09:50:00 Personalized medicine for children with cancer: challenges and specificities. GILLES VASSAL
10:15:00 Personalized therapies for cancer patients: dream vision or immediate necessity. JOHNATHAN KNOWLES
11:00:00 COFFEE BREAK AND NETWORK DISCUSSIONS
11:20:00 NPG AWARDS: THE WINNERS OF THE BEST RESEARCH PRESENTATIONS Lisa Hutchinson
11:30:00 Early diagnosis presentation.
11:50:00 Individualized tailored treatment presentation.
12:20:00 Innovative technologies in personalized cancer medicine presentation.
12:40:00 The Nature Publishing Group Awards.
13:00:00 LUNCH AND NETWORK DISCUSSIONS
14:25:00 Presentation of the WIN Consortium and its strategic partners: specific goals and projects for the upcoming year
14:30:00 Strategic Media Partnership with the Nature Publishing Group. JAMES BUTCHER, VLADIMIR LAZAR
15:15:00 Open Interactive Forum JOHN MENDELSOHN
17:00:00 CONCLUSION OF THE SECOND ANNUAL WIN SYMPOSIUM AND ADJOURN
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.